Why the study?
Heart failure has been an under-recognized complication of arrhythmogenic cardiomyopathy, and updated clinical management guidelines warranted a comprehensive review.
Design
Review
Authors
Loading...
Updated HF guidelines in ACM warrant clinical awareness; leaves open optimal strategies for prospective validation.
This review summarizes the updated clinical management guidelines and research progress regarding the epidemiology, clinical characteristics, risk stratification, and therapeutics of heart failure in patients with arrhythmogenic cardiomyopathy.
Chen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: